1 / 6

DISCUSSION

DISCUSSION. EUROCHIP-2 ACTION PLAN. COUNTRY 1. COUNTRY 2. COUNTRY 3. COUNTRY 30. ACTION 2. ACTION 3. ACTION 4. ACTION 5. ACTION 6. ACTION 6. ACTION 1. ACTION 3. ACTION 4. EUROPEAN PUBLIC HEALTH ACTIONS. Care and treatment Pilot studies. Epidemiology

dean
Download Presentation

DISCUSSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DISCUSSION

  2. EUROCHIP-2 ACTION PLAN COUNTRY 1 COUNTRY 2 COUNTRY 3 COUNTRY 30 ACTION 2 ACTION 3 ACTION 4 ACTION 5 ACTION 6 ACTION 6 ACTION 1 ACTION 3 ACTION 4 EUROPEAN PUBLIC HEALTH ACTIONS Care and treatment Pilot studies Epidemiology Promotion of cancer registration Early diagnosis Cervical screening Prevention Dietary prevention EU CANCER PLAN

  3. EUROCHIP ACTION ON SCREENING EUROPEAN INSTITUTE OF WOMEN'S HEALTH EUROPEAN CERVICAL CANCER INTEREST GROUP EIWH ECCIG ECPC ECN ECCA EUROPEAN CANCER PATIENT COALITION EUROPEAN CANCER NETWORK EUROPEAN CERVICAL CANCER ASSOCIATION

  4. EUROCHIP-3 • Together: Europe for Europeans • Fights against barriers • Assist in activities • Acceptability: relative successes • Scientific dissemination of results • Innovation • New applications in terms of organization, infrastructures etc

  5. EUROCHIP-3 WP proposal

  6. EUROCHIP-3 COMMON DISCUSSION • INFORMATION for general population, health professionals and policy makers • DIFFUSION OF GUIDELINES • COST REDUCTION (from country experience to common suggestions for Europe) in relation with WP5 • Data restriction problems for screening registries in relation with WP 3 (on cancer registration) and EUNICE • PROMOTION OF CANCER SCREENING REGISTRY (also for monitoring screening activities)

More Related